Hedge Fund - Tamarack Capital Management
Rigel Pharmaceuticals Inc (RIGL)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q3 (2023-09-30) | $0 | 0% | 0 | $12.03 |
| 2 | 2023 - Q2 (2023-06-30) | $1,612,500 | 0.49% | 125,000 | $13.52 |
| 3 | 2023 - Q1 (2023-03-31) | $2,640,000 | 0.96% | 200,000 | $15.89 |
| 4 | 2022 - Q4 (2022-12-31) | $3,450,000 | 1.77% | 230,000 | $9.17 |
| 5 | 2022 - Q3 (2022-09-30) | $2,360,000 | 1.38% | 200,000 | $13.53 |
| 6 | 2022 - Q2 (2022-06-30) | $2,260,000 | 1.3% | 200,000 | $20.08 |
| 7 | 2022 - Q1 (2022-03-31) | $9,718,000 | 4.64% | 325,000 | $27.07 |
| 8 | 2021 - Q4 (2021-12-31) | $11,925,000 | 4.9% | 450,000 | $30.17 |
| 9 | 2021 - Q3 (2021-09-30) | $25,410,000 | 8.02% | 700,000 | $39.36 |
| 10 | 2021 - Q2 (2021-06-30) | $27,776,000 | 7.86% | 640,000 | $37.75 |
| 11 | 2021 - Q1 (2021-03-31) | $28,557,000 | 5.85% | 835,000 | $39.60 |
| 12 | 2020 - Q4 (2020-12-31) | $25,963,000 | 5.43% | 745,000 | $28.95 |
| 13 | 2020 - Q3 (2020-09-30) | $18,000,000 | 5.56% | 750,000 | $24.55 |
| 14 | 2020 - Q2 (2020-06-30) | $12,536,000 | 3.49% | 685,000 | $17.99 |
| 15 | 2020 - Q1 (2020-03-31) | $8,658,000 | 3.27% | 555,000 | $21.28 |
| 16 | 2019 - Q4 (2019-12-31) | $11,788,000 | 2.69% | 575,000 | $20.59 |
| 17 | 2019 - Q3 (2019-09-30) | $10,238,000 | 2.66% | 547,500 | $20.66 |
| 18 | 2019 - Q2 (2019-06-30) | $14,016,000 | 4.26% | 547,500 | $22.57 |
| 19 | 2019 - Q1 (2019-03-31) | $13,621,000 | 5.4% | 530,000 | $22.86 |
| 20 | 2018 - Q4 (2018-12-31) | $12,650,000 | 5.15% | 550,000 | $28.22 |
| 21 | 2018 - Q3 (2018-09-30) | $14,606,000 | 4.17% | 455,000 | $30.02 |
| 22 | 2018 - Q2 (2018-06-30) | $7,429,000 | 2.48% | 262,500 | $35.59 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:10.0000 on 2024-06-27